AI-Powered Malaria Point-Of-Care Device
Healthcare Without Borders
Our solution can be deployed at scale in the field
What about RDTs?
Our solution can be deployed at scale in the field
At Biomicrology, we are driven to enhance global health equity. We aim to transform healthcare in underserved regions through technology, innovation, and collaboration.
Malaria is a serious disease, but timely and accurate diagnosis can lead to better outcomes. In areas where malaria is common, healthcare providers often struggle to assess the level of infection and determine whether a positive rapid diagnostic test (RDT) result indicates a current or past infection. This leads to unnecessary prescriptions of anti-malarial medications, self-medication, increased financial burdens, and even death. Tragically, one child dies almost every minute from this treatable disease.
Biochrome is our AI-powered point-of-care device for malaria diagnosis in resource-poor and endemic regions. With its advanced algorithms, Biochrome delivers lab-grade results within minutes, enabling reliable, swift and instant treatment.
Designed for portability, scalability, and ease of use, Biochrome empowers healthcare providers with a powerful tool to combat malaria one diagnosis at a time.
Our growing team comprises passionate individuals dedicated to improving global health equity. With diverse backgrounds and expertise, we combine a unique blend of skills and perspectives to drive innovation and impact.
BIOMICROLOGY PTY LTD ACN 666 776 218
Bedford Park, South Australia, Australia
Copyright © 2023 - 2024 Biomicrology -
All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.